These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1790471)
1. Crossover reaction between haloperidol and amoxapine for NMS. Otani K; Mihara K; Okada M; Kaneko S; Fukushima Y Br J Psychiatry; 1991 Dec; 159():889. PubMed ID: 1790471 [No Abstract] [Full Text] [Related]
2. Amoxapine and neuroleptic malignant syndrome. Lesaca T Am J Psychiatry; 1987 Nov; 144(11):1514. PubMed ID: 3118723 [No Abstract] [Full Text] [Related]
3. Neuroleptic malignant syndrome associated with amoxapine and lithium in an older adult. Gupta S; Racaniello AA Ann Clin Psychiatry; 2000 Jun; 12(2):107-9. PubMed ID: 10907803 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma. Balzan M; Cacciottolo JM Br J Psychiatry; 1992 Aug; 161():257-8. PubMed ID: 1521110 [TBL] [Abstract][Full Text] [Related]
5. NMS and haloperidol. Velamoor VR Can J Psychiatry; 1991 Dec; 36(10):764. PubMed ID: 1819264 [No Abstract] [Full Text] [Related]
10. Recurrent neuroleptic malignant syndrome in a man with mild mental handicap. Bambrick M; Wilson D J Intellect Disabil Res; 1992 Aug; 36 ( Pt 4)():377-81. PubMed ID: 1356040 [TBL] [Abstract][Full Text] [Related]
11. Recurrence of neuroleptic malignant syndrome via an inadvertent rechallenge in a woman with mental retardation. Boyd RD Ment Retard; 1992 Apr; 30(2):77-9. PubMed ID: 1584031 [TBL] [Abstract][Full Text] [Related]
12. Development of neuroleptic malignant syndrome during simultaneous amoxapine treatment and alprazolam discontinuation. Burch EA; Downs J J Clin Psychopharmacol; 1987 Feb; 7(1):55-6. PubMed ID: 3818996 [No Abstract] [Full Text] [Related]
13. Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors. Hermesh H; Huberman M; Radvan H; Kott E J Nerv Ment Dis; 1984 Nov; 172(11):692-5. PubMed ID: 6238132 [TBL] [Abstract][Full Text] [Related]
15. Comment: repetitive publication of amoxapine and NMS case report. Tam CW DICP; 1990 Jun; 24(6):646. PubMed ID: 2360348 [No Abstract] [Full Text] [Related]
16. Treatment of hypomania following neuroleptic malignant syndrome. Steadman P Biol Psychiatry; 1992 Jul; 32(1):104-5. PubMed ID: 1391291 [No Abstract] [Full Text] [Related]
17. [Case of malignant neuroleptic syndrome caused by an anti-depressive agent, later complicated by respiratory insufficiency and DIC]. Okamoto K; Umeno M; Takagi H; Nagano S; Takeda Y Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):727-9. PubMed ID: 9627481 [No Abstract] [Full Text] [Related]
18. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. Nisijima K; Ishiguro T J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156 [TBL] [Abstract][Full Text] [Related]
19. Combined neuroleptic malignant syndrome and the central anticholinergic syndrome. Bennett DA J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):711. PubMed ID: 2213055 [No Abstract] [Full Text] [Related]
20. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature]. Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]